BLUE

bluebird bio, Inc. Press Releases

$41.97
*  
0.72
1.69%
Get BLUE Alerts
*Delayed - data as of Nov. 25, 2014  -  Find a broker to begin trading BLUE now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    BLUE Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
bluebird bio Reports Fiscal Third Quarter 2014 Financial Results
11/12/2014 7:00:00 AM - Business Wire
▲0.48 % Price Change since this news event. The Volume Ratio is 0.72.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


James M. DeTore joins bluebird bio as Chief Financial Officer
11/10/2014 7:00:00 AM - Business Wire
▲2.29 % Price Change since this news event. The Volume Ratio is 0.87.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


bluebird bio to Present at Three Upcoming Health Care Conferences
11/7/2014 7:00:00 AM - Business Wire
▲0.55 % Price Change since this news event. The Volume Ratio is 0.29.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


bluebird bio to Present LentiGlobin Clinical Data at the American Society of Hematology Conference
11/6/2014 9:00:00 AM - Business Wire
▲7.59 % Price Change since this news event. The Volume Ratio is 1.88.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


bluebird bio Announces First Patient with Sickle Cell Disease Transplanted with LentiGlobin Gene Therapy
10/14/2014 7:00:00 AM - Business Wire
▲36.71 % Price Change since this news event. The Volume Ratio is 0.82.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


bluebird bio to Present at Morgan Stanley Global Health Care Conference
9/2/2014 5:30:00 PM - Business Wire